Home > News > NanoCure Changes Name to Avidimer Therapeutics
May 17th, 2005
NanoCure Changes Name to Avidimer Therapeutics
Abstract:
James R. Baker, Jr., M.D., Avidimer's chairman and chief scientific officer, commented, "The name Avidimer Therapeutics refers to our focus on cell-specific targeting of therapeutics and diagnostics through the use of novel branch-like polymers known as dendrimers, which avidly target diseased cells and have the potential to diagnose and treat cancer and other diseases more effectively and completely than current diagnostics and therapeutics. Their small size (less than 5nm) enables them to escape the blood stream through vascular pores, selectively target and treat tumor cells, and be cleared rapidly through the kidney. Preclinical studies have demonstrated the impressive ability of dendrimers to target diseased cells in the body."
Source:
genengnews.com
Bookmark:
| Related News Press |
Nanomedicine
Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025
Next-generation drug delivery innovation! DGIST develops precision therapeutics using exosomes April 25th, 2025
Multiphoton polymerization: A promising technology for precision medicine February 28th, 2025
Rice researchers harness gravity to create low-cost device for rapid cell analysis February 28th, 2025
Announcements
Enhancing power factor of p- and n-type single-walled carbon nanotubes April 25th, 2025
Tumor microenvironment dynamics: the regulatory influence of long non-coding RNAs April 25th, 2025
Ultrafast plasmon-enhanced magnetic bit switching at the nanoscale April 25th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||